|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lyme Disease (Borrelia spp) DNA, Qualitative Real-Time PCR, Blood [15777]
Test CodeS52515
CPT Codes
87801
Preferred Specimen
1 mL whole blood collected in an EDTA (lavender-top) tube
Minimum Volume
0.5 mL
Other Acceptable Specimens
Whole blood collected in an ACD (yellow-top) tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 7 days
Refrigerated: 7 days
Methodology
Real-Time Polymerase Chain Reaction
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Sun-Sat
Report Available
1 to 3 days
Clinical Significance
The diagnosis of Borreliosis is most often made by clinical examination combined with evidence of tick bite or exposure in endemic areas. Amplification of Borrelia genomic DNA from blood, fluids or tissues can support the diagnosis.